|
1
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grégoire V, Lefebvre JL, Licitra L and
Felip E; EHNS-ESMO-ESTRO Guidelines Working Group: Squamous cell
carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21
(Suppl 5):v184–v186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bernstein E, Caudy AA, Hammond SM and
Hannon GJ: Role for a bidentate ribonuclease in the initiation step
of RNA interference. Nature. 409:363–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeng Y and Cullen BR: Sequence
requirements for micro RNA processing and function in human cells.
RNA. 9:112–123. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arantes LM, Laus AC, Melendez ME, de
Carvalho AC, Sorroche BP, De Marchi PR, Evangelista AF,
Scapulatempo-Neto C, de Souza Viana L and Carvalho AL: MiR-21 as
prognostic biomarker in head and neck squamous cell carcinoma
patients undergoing an organ preservation protocol. Oncotarget.
8:9911–9921. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sousa LO, Sobral LM, Matsumoto CS,
Saggioro FP, López RV, Panepucci RA, Curti C, Silva WA Jr, Greene
LJ and Leopoldino AM: Lymph node or perineural invasion is
associated with low miR-15a, miR-34c and miR-199b levels in head
and neck squamous cell carcinoma. BBA Clin. 6:159–164. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hudcova K, Raudenska M, Gumulec J, Binkova
H, Horakova Z, Kostrica R, Babula P, Adam V and Masarik M:
Expression profiles of miR-29c, miR-200b and miR-375 in tumour and
tumour-adjacent tissues of head and neck cancers. Tumour Biol.
37:12627–12633. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koshizuka K, Hanazawa T, Fukumoto I,
Kikkawa N, Okamoto Y and Seki N: The microRNA signatures:
Aberrantly expressed microRNAs in head and neck squamous cell
carcinoma. J Hum Genet. 62:3–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Carvalho AC, Scapulatempo-Neto C, Maia
DC, Evangelista AF, Morini MA, Carvalho AL and Vettore AL: Accuracy
of microRNAs as markers for the detection of neck lymph node
metastases in patients with head and neck squamous cell carcinoma.
BMC Med. 13:1082015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hou B, Ishinaga H, Midorikawa K, Shah SA,
Nakamura S, Hiraku Y, Oikawa S, Murata M and Takeuchi K:
Circulating microRNAs as novel prognosis biomarkers for head and
neck squamous cell carcinoma. Cancer Biol Ther. 16:1042–1046. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hui AB, Lenarduzzi M, Krushel T, Waldron
L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B,
Waldron J, et al: Comprehensive MicroRNA profiling for head and
neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramdas L, Giri U, Ashorn CL, Coombes KR,
El-Naggar A, Ang KK and Story MD: miRNA expression profiles in head
and neck squamous cell carcinoma and adjacent normal tissue. Head
Neck. 31:642–654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rahimy E, Kuo SZ and Ongkeko WM:
Evaluation of non-coding RNAs as potential targets in head and neck
squamous cell carcinoma cancer stem cells. Curr Drug Targets.
15:1247–1260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang D, Bian G, Pan Y, Han X, Sun Y, Wang
Y, Shen G, Cheng M, Fang X and Hu S: MiR-20a-5p promotes
radio-resistance by targeting Rab27B in nasopharyngeal cancer
cells. Cancer Cell Int. 17:322017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Wang X, Cheng J, Wang Z, Jiang T,
Hou N, Liu N, Song T and Huang C: MicroRNA-20a-5p targets RUNX3 to
regulate proliferation and migration of human hepatocellular cancer
cells. Oncol Rep. 36:3379–3386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng D, Zhao S, Tang H, Zhang D, Sun H,
Yu F, Jiang W, Yue B, Wang J, Zhang M, et al: MicroRNA-20a-5p
promotes colorectal cancer invasion and metastasis by
downregulating Smad4. Oncotarget. 7:45199–45213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Liu F, Xu Z, Guo N, Zheng X and
Sun C: Chemokine receptor 7 via proline-rich tyrosine kinase-2
upregulates the chemotaxis and migration ability of squamous cell
carcinoma of the head and neck. Oncol Rep. 28:1659–1664. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Zhang X, Thomas SM, Grandis JR,
Wells A, Chen ZG and Ferris RL: Chemokine receptor 7 activates
phosphoinositide-3 kinase-mediated invasive and prosurvival
pathways in head and neck cancer cells independent of EGFR.
Oncogene. 24:5897–5904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li P, Liu F, Sun L, Zhao Z, Ding X, Shang
D, Xu Z and Sun C: Chemokine receptor 7 promotes cell migration and
adhesion in metastatic squamous cell carcinoma of the head and neck
by activating integrin alphavbeta3. Int J Mol Med. 27:679–687.
2011.PubMed/NCBI
|
|
20
|
Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH and
Sun CF: CCL19-induced chemokine receptor 7 activates the
phosphoinositide-3 kinase-mediated invasive pathway through Cdc42
in metastatic squamous cell carcinoma of the head and neck. Oncol
Rep. 25:729–737. 2011.PubMed/NCBI
|
|
21
|
Liu FY, Zhao ZJ, Li P, Ding X, Guo N, Yang
LL, Zong ZH and Sun CF: NF-κB participates in chemokine receptor
7-mediated cell survival in metastatic squamous cell carcinoma of
the head and neck. Oncol Rep. 25:383–391. 2011.PubMed/NCBI
|
|
22
|
Fan X, Liu Y, Jiang J, Ma Z, Wu H, Liu T,
Liu M, Li X and Tang H: miR-20a promotes proliferation and invasion
by targeting APP in human ovarian cancer cells. Acta Biochim
Biophys Sin. 42:318–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang HW, Wang F, Wei Q, Zhao YF, Liu M, Li
X and Tang H: miR-20a promotes migration and invasion by regulating
TNKS2 in human cervical cancer cells. FEBS Lett. 586:897–904. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Zhang Z, Yu M, Li L, Du G, Xiao W
and Yang H: Involvement of miR-20a in promoting gastric cancer
progression by targeting early growth response 2 (EGR2). Int J Mol
Sci. 14:16226–16239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou J, Liu R, Luo C, Zhou X, Xia K, Chen
X, Zhou M, Zou Q, Cao P and Cao K: MiR-20a inhibits cutaneous
squamous cell carcinoma metastasis and proliferation by directly
targeting LIMK1. Cancer Biol Ther. 15:1340–1349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiong Y, Zhang L and Kebebew E: MiR-20a is
upregulated in anaplastic thyroid cancer and targets LIMK1.
PLoS One. 9:e961032014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang CC, Yang YJ, Li YJ, Chen ST, Lin BR,
Wu TS, Lin SK, Kuo MY and Tan CT: MicroRNA-17/20a functions to
inhibit cell migration and can be used a prognostic marker in oral
squamous cell carcinoma. Oral Oncol. 49:923–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu J, Ge W and Xu J: HPV 16 E7 inhibits
OSCC cell proliferation, invasion, and metastasis by upregulating
the expression of miR-20a. Tumour Biol. 37:9433–9440. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu Z, Willmarth NE, Zhou J, Katiyar S,
Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP and Pestell RG:
microRNA 17/20 inhibits cellular invasion and tumor metastasis in
breast cancer by heterotypic signaling. Proc Natl Acad Sci USA.
107:8231–8236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh B, Ronghe AM, Chatterjee A, Bhat NK
and Bhat HK: MicroRNA-93 regulates NRF2 expression and is
associated with breast carcinogenesis. Carcinogenesis.
34:1165–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu S, Patel SH, Ginestier C, Ibarra I,
Martin-Trevino R, Bai S, McDermott SP, Shang L, Ke J, Ou SJ, et al:
MicroRNA93 regulates proliferation and differentiation of normal
and malignant breast stem cells. PLoS Genet. 8:e10027512012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan G, Bauer JH, Haridas V, Wang S, Liu D,
Yu G, Vincenz C, Aggarwal BB, Ni J and Dixit VM: Identification and
functional characterization of DR6, a novel death domain-containing
TNF receptor. FEBS Lett. 431:351–356. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sedý J, Bekiaris V and Ware CF: Tumor
necrosis factor superfamily in innate immunity and inflammation.
Cold Spring Harb Perspect Biol. 7:a0162792014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pfeffer K: Biological functions of tumor
necrosis factor cytokines and their receptors. Cytokine Growth
Factor Rev. 14:185–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thorburn A: Death receptor-induced cell
killing. Cell Signal. 16:139–144. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tisch M, Kyrberg H, Weidauer H, Mytilineos
J, Conradt C, Opelz G and Maier H: Human leukocyte antigens and
prognosis in patients with head and neck cancer: Results of a
prospective follow-up study. Laryngoscope. 112:651–657. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sharma N, Benechet AP, Lefrancois L and
Khanna KM: CD8 T cells enter the Splenic T cell zones independently
of CCR7, but the subsequent expansion and trafficking patterns of
effector T cells after infection are dysregulated in the absence of
CCR7 migratory cues. J Immunol. 195:5227–5236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takanami I: Overexpression of CCR7 mRNA in
nonsmall cell lung cancer: Correlation with lymph node metastasis.
Int J Cancer. 105:186–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mashino K, Sadanaga N, Yamaguchi H, Tanaka
F, Ohta M, Shibuta K, Inoue H and Mori M: Expression of chemokine
receptor CCR7 is associated with lymph node metastasis of gastric
carcinoma. Cancer Res. 62:2937–2941. 2002.PubMed/NCBI
|
|
40
|
Ding Y, Shimada Y, Maeda M, Kawabe A,
Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H and Imamura
M: Association of CC chemokine receptor 7 with lymph node
metastasis of esophageal squamous cell carcinoma. Clin Cancer Res.
9:3406–3412. 2003.PubMed/NCBI
|
|
41
|
Kasof GM, Lu JJ, Liu D, Speer B, Mongan
KN, Gomes BC and Lorenzi MV: Tumor necrosis factor-alpha induces
the expression of DR6, a member of the TNF receptor family, through
activation of NF-kappaB. Oncogene. 20:7965–7975. 2001. View Article : Google Scholar : PubMed/NCBI
|
